This section presents the latest developments, inventions, and revolutionary technologies that change the face of healthcare.
QuantalX, the developer of the Delphi-MD neurodiagnostic device, has recently announced that the FDA has awarded it breakthrough designation status. This prestigious designation has been granted for the device's application in diagnosing patients...
Anumana, a leading AI-driven health technology company, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its ECG-AI algorithm designed to aid in the early identification of cardiac amyloidosis....
Avertix Medical, Inc., formerly known as Angel Medical Systems, Inc., has partnered with AdventHealth Orlando, a renowned hospital system in Florida, to introduce the Guardian™ System....
Cue Health, a healthcare technology company listed on Nasdaq under the ticker symbol HLTH, has achieved a significant milestone by becoming the first company to receive De Novo authorization from the U.S. Food and Drug Administration...
Researchers at Penn State University are currently working on the development of a wireless rechargeable battery specifically designed for biomedical electronics, such as cardiac pacemakers. The objective is to create a battery system that can be charged and managed without the need for invasive surgery....
FX has recently received FDA clearance for its latest innovation, the FX V135™ Shoulder System. This groundbreaking system stands as the first and only interlocking shoulder system with intraoperative options between 135° and 145° for reverse total shoulder arthroplasty. It introduces a range of advancements to the field of shoulder arthroplasty....
CorNeat Vision has announced that its EverPatch, a synthetic tissue substitute, has received 510(k) clearance from the US Food & Drug Administration (FDA). The clearance makes CorNeat EverPatch the world's first non-degradable...
DirectSync Surgical, a company specializing in medical devices for spine and orthopedic conditions, has announced that its patient-powered smart spinal fusion device has received Breakthrough Device Designation from the US Food and Drug Administration...
Paradromics, a leading developer of high data-rate brain-computer interfaces (BCI), has successfully raised $33 million in a Series A funding round. The funding round was led by Prime Movers Lab and included participation from Westcott Investment Group...
QuantalX, the developer of the Delphi-MD neurodiagnostic device, has received a prestigious FDA breakthrough designation for its innovative technology in diagnosing Normal Pressure Hydrocephalus (NPH) and predicting the response to ventriculoperitoneal shunting surgery (VPS) treatment....
